Stocktoria
BridgeBio Pharma, Inc. BBIO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2019-06-27
BridgeBio Pharma, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| VIKING GLOBAL INVESTORS LP | 14,393,934 | $1.1B |
| BlackRock Finance, Inc. | 12,448,272 | $315.3M |
| CITADEL ADVISORS LLC | 3,390,240 | $251.8M |
| TWO SIGMA INVESTMENTS, LP | 3,120,631 | $231.7M |
| D. E. Shaw & Co., Inc. | 2,545,486 | $189.0M |
| MILLENNIUM MANAGEMENT LLC | 633,283 | $47.0M |
| RENAISSANCE TECHNOLOGIES LLC | 365,772 | $27.2M |
| Bridgewater Associates, LP | 259,459 | $19.3M |
Source: SEC EDGAR filings · CIK 0001743881 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.